Navafenterol (AZD8871) in patients with COPD: a randomized,...

Respiratory Research 2020 / 09 Vol. 21; Iss. S1

Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator

Singh, Dave, Balaguer, Victor, Astbury, Carol, Wählby-Hamrén, Ulrika, Jimenez, Eulalia, Seoane, Beatriz, Villarroel, Cristina, Lei, Alejhandra, Aggarwal, Ajay, Psallidas, Ioannis
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Journal:
Respiratory Research
DOI:
10.1186/s12931-020-01347-7
Date:
September, 2020
File:
PDF, 826 KB
2020
Conversion to is in progress
Conversion to is failed